KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Equity Ratio: 2010-2014

Historic Equity Ratio for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to 0.55.

  • Biocryst Pharmaceuticals' Equity Ratio fell 24.27% to 0.46 in Q3 2015 from the same period last year, while for Sep 2015 it was 0.46, marking a year-over-year decrease of 24.27%. This contributed to the annual value of 0.55 for FY2014, which is 2498.12% up from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Equity Ratio stood at 0.55 for FY2014, which was up 2,498.12% from -0.02 recorded in FY2013.
  • Biocryst Pharmaceuticals' 5-year Equity Ratio high stood at 0.60 for FY2010, and its period low was -0.02 during FY2013.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Equity Ratio value was -0.01 (recorded in 2012), while the average stood at 0.17.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Equity Ratio crashed by 191.53% in 2013, and later surged by 2,498.12% in 2014.
  • Yearly analysis of 5 years shows Biocryst Pharmaceuticals' Equity Ratio stood at 0.60 in 2010, then plummeted by 69.91% to 0.18 in 2011, then slumped by 104.39% to -0.01 in 2012, then crashed by 191.53% to -0.02 in 2013, then spiked by 2,498.12% to 0.55 in 2014.